1. Home
  2. ICU

as 10-07-2025 3:30pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Founded: 2018 Country:
United States
United States
Employees: N/A City: DENVER
Market Cap: 25.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 3.8M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.02 EPS Growth: N/A
52 Week Low/High: $0.31 - $4.28 Next Earning Date: 11-12-2025
Revenue: $766,000 Revenue Growth: N/A
Revenue Growth (this year): 820% Revenue Growth (next year): 63.37%

Share on Social Networks: